574 related articles for article (PubMed ID: 29359795)
1. Recent advances in developing specific therapies for haemophilia.
Ling G; Nathwani AC; Tuddenham EGD
Br J Haematol; 2018 Apr; 181(2):161-172. PubMed ID: 29359795
[TBL] [Abstract][Full Text] [Related]
2. Haemophilia: factoring in new therapies.
Fassel H; McGuinn C
Br J Haematol; 2021 Sep; 194(5):835-850. PubMed ID: 34322873
[TBL] [Abstract][Full Text] [Related]
3. A golden age for Haemophilia treatment?
Makris M; Hermans C
Haemophilia; 2018 Mar; 24(2):175-176. PubMed ID: 29601683
[No Abstract] [Full Text] [Related]
4. The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing.
Mancuso ME; Mahlangu JN; Pipe SW
Lancet; 2021 Feb; 397(10274):630-640. PubMed ID: 33460559
[TBL] [Abstract][Full Text] [Related]
5. [Gene therapy of haemophilia - has the cure come within reach?].
Kaczmarek R
Postepy Biochem; 2018 Dec; 64(4):318-322. PubMed ID: 30656916
[TBL] [Abstract][Full Text] [Related]
6. The past and future of haemophilia: diagnosis, treatments, and its complications.
Peyvandi F; Garagiola I; Young G
Lancet; 2016 Jul; 388(10040):187-97. PubMed ID: 26897598
[TBL] [Abstract][Full Text] [Related]
7. Emerging genetic and pharmacologic therapies for controlling hemostasis: beyond recombinant clotting factors.
Monahan PE
Hematology Am Soc Hematol Educ Program; 2015; 2015():33-40. PubMed ID: 26637698
[TBL] [Abstract][Full Text] [Related]
8. Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play?
Hazendonk HCAM; van Moort I; Mathôt RAA; Fijnvandraat K; Leebeek FWG; Collins PW; Cnossen MH;
Blood Rev; 2018 Jul; 32(4):265-271. PubMed ID: 29426727
[TBL] [Abstract][Full Text] [Related]
9. The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges.
Trinchero A; Sholzberg M; Matino D
Hamostaseologie; 2020 Aug; 40(3):311-321. PubMed ID: 32726826
[TBL] [Abstract][Full Text] [Related]
10. New therapies for hemophilia.
Weyand AC; Pipe SW
Blood; 2019 Jan; 133(5):389-398. PubMed ID: 30559264
[TBL] [Abstract][Full Text] [Related]
11. A Molecular Revolution in the Treatment of Hemophilia.
Butterfield JSS; Hege KM; Herzog RW; Kaczmarek R
Mol Ther; 2020 Apr; 28(4):997-1015. PubMed ID: 31843450
[TBL] [Abstract][Full Text] [Related]
12. The evolution of recombinant factor replacement for hemophilia.
Sankar AD; Weyand AC; Pipe SW
Transfus Apher Sci; 2019 Oct; 58(5):596-600. PubMed ID: 31421983
[TBL] [Abstract][Full Text] [Related]
13. Looking to the future of gene therapy for hemophilia A and B.
Kaczmarek R; Herzog RW
Expert Rev Hematol; 2023; 16(11):807-809. PubMed ID: 37798911
[No Abstract] [Full Text] [Related]
14. Role of enhanced half-life factor VIII and IX in the treatment of haemophilia.
Mahdi AJ; Obaji SG; Collins PW
Br J Haematol; 2015 Jun; 169(6):768-76. PubMed ID: 25754016
[TBL] [Abstract][Full Text] [Related]
15. How I manage patients with inherited haemophilia A and B and factor inhibitors.
Ljung RCR
Br J Haematol; 2018 Feb; 180(4):501-510. PubMed ID: 29270992
[TBL] [Abstract][Full Text] [Related]
16. Prevention and Management of Bleeding Episodes in Children with Hemophilia.
Ljung RCR
Paediatr Drugs; 2018 Oct; 20(5):455-464. PubMed ID: 30128815
[TBL] [Abstract][Full Text] [Related]
17. Gene Therapy for Hemophilia.
Nathwani AC; Davidoff AM; Tuddenham EGD
Hematol Oncol Clin North Am; 2017 Oct; 31(5):853-868. PubMed ID: 28895852
[TBL] [Abstract][Full Text] [Related]
18. Hemophilia in a Changing Treatment Landscape.
Pelland-Marcotte MC; Carcao MD
Hematol Oncol Clin North Am; 2019 Jun; 33(3):409-423. PubMed ID: 31030810
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the management of haemophilia and christmas disease.
Biggs R
Clin Haematol; 1979 Feb; 8(1):95-114. PubMed ID: 367667
[No Abstract] [Full Text] [Related]
20. Advances in Gene Therapy for Hemophilia.
Nathwani AC; Davidoff AM; Tuddenham EGD
Hum Gene Ther; 2017 Nov; 28(11):1004-1012. PubMed ID: 28835123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
